3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Phase 2
1
Status
Recruiting
2
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
2
Conditions
Glioblastoma
2
Interventions
Temozolomide
45
Radiotherapy
17
Magnetic Resonance Spectroscopy
17
Specimen Handling
14
pembrolizumab
12
Bevacizumab
12
Lomustine
9
Radiation
8
fludarabine
7
Cyclophosphamide
7
atezolizumab
4
Biopsy
4
olaparib
3
Transurethral Resection of Bladder
3
Surgical Procedures, Operative
3
Nivolumab
3
Leukapheresis
3
D2C7-(scdsFv)-PE38KDEL
3
Blood Specimen Collection
3
Aminolevulinic Acid
3
regorafenib
2
fluciclovine F-18
2
contrast agent BR1
2
antisecretory factor
2
abemaciclib
2
Restraint, Physical
2
Re-Irradiation
2
Radiation Dose Hypofractionation
2
Palliative Care
2
Oncolytic Virotherapy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Glioblastoma
×
antisecretory factor
×
Clear all
NCT07364786
2026-01-23
AFGBMBiop
Skane University Hospital
Phase 2
Recruiting
10 enrolled
NCT05669820
2026-01-09
AFGB2
Skane University Hospital
Phase 2/3
Recruiting
300 enrolled